Sana Biotechnology (SANA) News Today $2.53 +0.17 (+7.20%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Comparing Sana Biotechnology (NASDAQ:SANA) and Tectonic Therapeutic (NASDAQ:TECX)November 21 at 5:13 AM | americanbankingnews.comSana Biotechnology: The Story Becomes MurkierNovember 19 at 6:21 PM | seekingalpha.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANANovember 18 at 9:52 PM | prnewswire.comSana Biotechnology (NASDAQ:SANA) Reaches New 1-Year Low - Here's WhySana Biotechnology (NASDAQ:SANA) Hits New 12-Month Low - Time to Sell?November 18 at 11:09 AM | marketbeat.comDid Sana Biotechnology, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- SANANovember 15, 2024 | stockhouse.comBaillie Gifford & Co. Sells 293,116 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Baillie Gifford & Co. lessened its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 2.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,278,084 shares of the company's stock after selling 293,116 shares dNovember 13, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Hits New 1-Year Low - What's Next?Sana Biotechnology (NASDAQ:SANA) Sets New 1-Year Low - Here's What HappenedNovember 11, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Sana Biotechnology (NASDAQ:SANA)HC Wainwright reaffirmed a "buy" rating and set a $8.00 price target on shares of Sana Biotechnology in a research note on Monday.November 11, 2024 | marketbeat.comBalanced Hold Rating on Sana Biotechnology Amid Delayed Program Timelines and Financial ChallengesNovember 11, 2024 | markets.businessinsider.comSana Biotechnology, Inc. Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comOptimistic Buy Rating for Sana Biotechnology Amid Strategic Advancements and High Return PotentialNovember 8, 2024 | markets.businessinsider.comSana Biotechnology Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 8, 2024 | globenewswire.comHC Wainwright Issues Positive Forecast for SANA EarningsSana Biotechnology, Inc. (NASDAQ:SANA - Free Report) - Investment analysts at HC Wainwright lifted their Q3 2024 EPS estimates for shares of Sana Biotechnology in a note issued to investors on Tuesday, November 5th. HC Wainwright analyst E. Bodnar now anticipates that the company will earn ($0.25November 7, 2024 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Sana Biotechnology (SANA)November 7, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Stock Quotes, Forecast and News SummaryNovember 6, 2024 | benzinga.comJMP Securities Downgrades Sana Biotechnology (SANA)November 6, 2024 | msn.comSana Biotechnology price target lowered to $8 from $11 at H.C. WainwrightNovember 6, 2024 | markets.businessinsider.comSana Biotechnology downgraded to Market Perform from Outperform at JMP SecuritiesNovember 5, 2024 | markets.businessinsider.comSana lowered to market perform by JMP over data uncertaintyNovember 5, 2024 | msn.comSana Biotechnology (NASDAQ:SANA) Sets New 12-Month Low After Analyst DowngradeSana Biotechnology (NASDAQ:SANA) Hits New 1-Year Low on Analyst DowngradeNovember 5, 2024 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Sana Biotechnology (NASDAQ:SANA) Stock PriceHC Wainwright lowered their price target on Sana Biotechnology from $11.00 to $8.00 and set a "buy" rating on the stock in a report on Tuesday.November 5, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Rating Lowered to "Market Perform" at JMP SecuritiesJMP Securities downgraded Sana Biotechnology from an "outperform" rating to a "market perform" rating in a research report on Tuesday.November 5, 2024 | marketbeat.comSana Biotechnology to focus on SC291, suspends SC291 in oncology and SC379November 5, 2024 | markets.businessinsider.comSana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025November 4, 2024 | globenewswire.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6% - Time to Sell?Sana Biotechnology (NASDAQ:SANA) Stock Price Down 6.6% - What's Next?October 29, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Up 7.7% - Here's What HappenedSana Biotechnology (NASDAQ:SANA) Trading Up 7.7% - Here's What HappenedOctober 28, 2024 | marketbeat.comJ.P. Morgan Sticks to Their Hold Rating for Sana Biotechnology (SANA)October 22, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 6.4% - What's Next?Sana Biotechnology (NASDAQ:SANA) Shares Down 6.4% - Time to Sell?October 21, 2024 | marketbeat.comIs Sana Biotechnology (NASDAQ:SANA) In A Good Position To Deliver On Growth Plans?October 18, 2024 | finance.yahoo.comWhy Sana Biotechnology, Inc. (SANA) is the Penny Stock with the Biggest Upside Potential According to AnalystsOctober 16, 2024 | msn.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Marshall Wace LLPMarshall Wace LLP decreased its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 78.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,713 shares of the company's stock after selOctober 8, 2024 | marketbeat.comA*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in SingaporeOctober 3, 2024 | finance.yahoo.comSana Biotechnology to Present at the Goldman Sachs Cell Therapy Day ConferenceSeptember 30, 2024 | globenewswire.comSana Biotechnology, Inc. (NASDAQ:SANA) Director Sells $612,000.00 in StockSeptember 27, 2024 | insidertrades.comMassachusetts Financial Services Co. MA Reduces Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA)Massachusetts Financial Services Co. MA reduced its position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 75.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 58,801 shares of the compSeptember 24, 2024 | marketbeat.comIntegral Health Asset Management LLC Increases Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)Integral Health Asset Management LLC grew its holdings in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 22.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,200,000 shares of the companSeptember 23, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 4.1%Sana Biotechnology (NASDAQ:SANA) Stock Price Down 4.1%September 20, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Trading Up 9.6%Sana Biotechnology (NASDAQ:SANA) Trading Up 9.6%September 19, 2024 | marketbeat.comTD Asset Management Inc Has $2.21 Million Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA)TD Asset Management Inc reduced its position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 22.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 404,348 sharesSeptember 14, 2024 | marketbeat.comTech Moves: SheerID adds revenue chief; Sana CFO stepping down; Seattle HR vet launches new firmSeptember 13, 2024 | msn.comSana Biotechnology CFO Nathan Hardy to ResignSeptember 12, 2024 | marketwatch.comSana Biotechnology (NASDAQ:SANA) Shares Down 3.4% Sana Biotechnology (NASDAQ:SANA) Stock Price Down 3.4%September 12, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Trading Down 4.8%Sana Biotechnology (NASDAQ:SANA) Trading Down 4.8%September 6, 2024 | marketbeat.comSana Biotechnology to Present at September 2024 Investor ConferencesAugust 30, 2024 | markets.businessinsider.comSana Biotechnology (NASDAQ:SANA) Trading Up 7.2%Sana Biotechnology (NASDAQ:SANA) Stock Price Up 7.2%August 29, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Down 4.1% Sana Biotechnology (NASDAQ:SANA) Trading Down 4.1%August 27, 2024 | marketbeat.comSana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific OfficerAugust 26, 2024 | globenewswire.comBaillie Gifford & Co. Sells 85,079 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Baillie Gifford & Co. trimmed its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 0.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,571,200 shares of theAugust 25, 2024 | marketbeat.comIAN BREMMER, ANIMA ANANDKUMAR AND JAMES GORMAN TO HEADLINE 2024 NACD DIRECTORS SUMMIT™August 23, 2024 | finance.yahoo.comSana Biotechnology (NASDAQ:SANA) Stock Price Up 5.8%Sana Biotechnology (NASDAQ:SANA) Shares Up 5.8%August 21, 2024 | marketbeat.com Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin SANA Media Mentions By Week SANA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SANA News Sentiment▼-0.020.46▲Average Medical News Sentiment SANA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SANA Articles This Week▼43▲SANA Articles Average Week Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FLGT News Today ALLO News Today SAGE News Today FATE News Today EDIT News Today NKTR News Today BLUE News Today DTIL News Today BEAM News Today APGE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SANA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
